[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Andrew Brunner, MD

Specialities: Myelodysplastic Syndromes, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia

Spoken languages: English

Clinical Expertise

  • Acute Myeloid Leukemia
  • Myelodysplastic syndrome
  • Acute Lymphocytic Leukemia

About

Myelodysplastic syndromes are disorders of the bone marrow associated with bone marrow failure and a risk of progression to acute myeloid leukemia. My clinical area of focus and research projects are focused toward understanding treatment patterns and patient outcomes in MDS and other advanced hematologic malignancies, and to develop new treatments for these patients. The therapies available for patients with MDS have not changed in the last decade, and there is critical need to develop new agents and identify the patients most likely to benefit from a given chemotherapy. I am involved in clinical trials for all stages of MDS with an overall goal of tailoring treatment to improve the outcomes of these patients.

Location

Massachusetts General Hospital: 55 Fruit St, Boston, MA 02114, USA

newsletter icon

Get the latest thought leadership on your Myelodysplastic Syndromes delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.

Thanks to our HealthTree Community for Myelodysplastic Syndromes Sponsors:

AbbVie
Bristol Myers Squibb

Follow Us

facebook instagram youtube